Cardiac Monitors in Illinois

Baxter Healthcare Corporation is a global medical device and pharmaceutical company serving hospitals, physician offices, and home care settings. The company manufactures and distributes essential solutions across primary care, hospital care, surgical care, nutritional care, and respiratory care. Baxter's portfolio includes infusion pumps and IV delivery systems (notably used in chemotherapy and critical care), cardiac monitoring and vital signs equipment, ventilators and oxygen therapy devices, nutritional support products, and vision screening systems. The company emphasizes connected care and digital health integration, addressing the fragmentation of isolated medical devices through data connectivity and clinical workflow optimization. Baxter serves inpatient acute care, intensive care units, operating rooms, outpatient clinics, and home healthcare environments. The company has over 90 years of operational history and maintains substantial manufacturing and supply chain capabilities. Products are designed for use by nurses, physicians, and other clinical staff in hospitals, ICUs, surgical suites, and residential settings. Baxter's regulatory footprint includes FDA-cleared and internationally approved devices. The organization operates under a mission framework emphasizing patient safety, clinical efficiency, and care outcomes improvement.

Endotronix is a cardiovascular medical device company specializing in remote hemodynamic monitoring systems for heart failure management. The company manufactures the Cordella PA Sensor and HF System, an FDA-approved implantable pulmonary artery pressure sensor designed for patients with NYHA class III heart failure. The Cordella system enables proactive, remote monitoring by collecting daily pulmonary artery pressure data alongside vital signs including blood pressure, weight, heart rate, and blood oxygen saturation. The integrated HF management platform provides clinicians with comprehensive, trended health data to guide medication optimization and reduce hospitalizations. Clinical evidence demonstrates the system achieved a 73% reduction in heart failure hospitalization rates at 12 months and a low 12-month hospitalization/all-cause mortality rate (0.36) in the PROACTIVE-HF trial. The platform combines patient-facing monitoring tools with clinician-directed workflows that align with care delivery models and support reimbursement. The company holds FDA approval for the Cordella system and focuses on advancing guideline-directed medical therapy adoption. Endotronix was acquired by Edwards Lifesciences in 2024 for $1.2 billion, integrating its hemodynamic monitoring technology into a major cardiovascular device portfolio.

inomed Inc., USA is the US subsidiary of inomed Medizintechnik GmbH, a German medical device manufacturer with 30+ years of expertise in intraoperative neuromonitoring (IOM). The company specializes in complete IOM solutions for Head & Neck surgical procedures, providing systems, accessories, and on-site support to surgeons and healthcare facilities. Their core product line includes the C2 NerveMonitor and associated monitoring accessories designed to enhance patient and surgeon safety during surgery by enabling real-time neurophysiological monitoring. Manufacturing adheres to German quality standards, and the company emphasizes direct customer support, comprehensive service packages, and worldwide distribution capabilities. inomed serves specialists globally and has supported millions of patients through its neurophysiological monitoring technology. The company operates an e-commerce platform for orders and provides both hardware systems and consumable accessories for intraoperative monitoring applications.

Prolaio Inc. is an FDA-cleared software platform designed to unite patients, care teams, and clinical researchers in cardiology through secure, technology-enabled data collection and analysis. The company develops real-world clinical data solutions specifically focused on heart disease management and drug development acceleration. Prolaio's platform collects continuous, high-density on-body patient data and applies advanced machine learning algorithms to synthesize meaningful clinical insights for treatment decisions and research optimization. The platform serves three primary user groups: patients receiving continuous heart health monitoring integrated with their care teams, care teams making longitudinal treatment decisions based on synthesized clinical data, and clinical researchers seeking high-density datasets to optimize study design and reduce trial overhead. The company has developed 40+ proven algorithms with 5 FDA-cleared algorithms currently deployed. Prolaio has accumulated over 4 million hours of on-body patient data across operations in 26+ countries. The company holds 20+ issued patents in machine learning and clinical data analytics. With 30+ years of cumulative machine learning expertise embedded in its platform, Prolaio addresses the significant clinical and economic burden of heart disease—the leading cause of death in the United States and responsible for 1.3 million preventable hospitalizations annually. The platform is designed to accelerate cardiology breakthroughs, improve patient outcomes, and streamline clinical research workflows by providing actionable, real-world clinical intelligence.

ATCOR Medical is a cardiovascular diagnostics company specializing in vascular biomarker monitoring through their SphygmoCor technology platform. The company develops clinical-grade software and hardware systems for non-invasive vascular assessment, central blood pressure measurement, and arterial stiffness analysis. Primary product is the SphygmoCor XCEL System, a digital vascular biomarker monitoring platform designed for clinical practice, academic research, and clinical trials. The company offers XCEL V1.3 base software installation, XCEL Secure Data Option (Part 11 compliant for regulated environments), and calibration kit software for annual system maintenance. ATCOR serves hospitals, clinics, research institutions, and clinical trial organizations globally. The company maintains offices in the USA (Naperville, Illinois), Australia (Sydney), and China (Shanghai), with an authorized distributor network. Technical support and software downloads are managed through their conneqthealth.com platform. Products are positioned for cardiovascular risk assessment and vascular health monitoring in both clinical and research settings.

ASCEND Cardiovascular is a specialized cardiovascular IT solutions provider headquartered in Springfield, Illinois. Founded in 1995, the company develops enterprise-grade structured reporting and workflow software designed exclusively for cardiology departments and health systems. The ASCEND CV portfolio delivers multimodality structured reporting capabilities that integrate diagnostic, procedural, and reporting workflows into a unified cardiovascular ecosystem. Core offerings include ASCEND CV (multimodality reporting software), ASCEND InView (zero-footprint DICOM viewer), Gen3Echo (AI-driven echocardiography reporting), ASCEND Analytics (open-schema data warehouse), and Catalyst LIVE (telepresence collaboration platform). The company provides vendor-agnostic solutions with device interfaces, clinical decision support, and implementation services. ASCEND serves leading North American health systems and hospitals, with specialized solutions for pediatric cardiology, congenital heart disease, and non-invasive cardiac imaging. The platform integrates seamlessly with major EHR/HIS systems and medical device manufacturers including Epic, Cerner, GE Healthcare, Philips, and AGFA Healthcare.

Medtec Medical, Inc. is an established medical supplier with over 30 years of operational history, specializing in infusion therapy supplies, pharmacy compliance equipment, and patient safety devices. The company's primary product portfolio centers on infusion therapy consumables including IV administration sets, IV bags (gravity, dual chamber, legless, and 2-port configurations), extension sets, transfer sets, and stopcocks. They offer the Ambit Infusion Pump for ICU and clinical settings. Medtec Medical provides comprehensive pharmacy compliance solutions addressing USP 797 requirements, including aseptic technique supplies, sterility testing kits, endotoxin testing, growth media, hazardous drug handling equipment, incubators, rinse fluids, syringe filters, and vial adaptors. The company also supplies falls prevention equipment such as disposable bed and chair pads with monitoring capabilities, urine detection pads, and chair/bed monitors with voice recording functionality. Additional offerings include vascular access kits (basic, interventional radiology, midline, and nurse kits), compression therapy equipment (DVT pumps), and antimicrobial stethoscopes for cardiology and legacy applications. Product lines span hospital-grade consumables and durable equipment designed for acute care, critical care, and ambulatory settings. The company maintains a direct-to-hospital and healthcare provider distribution model with call-for-price quotation structures on many specialty items.

Sunset Healthcare Solutions is a Chicago-based manufacturer and wholesale distributor specializing in respiratory-focused medical equipment and consumable supplies for homecare, hospitals, and acute care settings. Founded in 2004, the company offers CPAP therapy equipment, oxygen delivery and concentrator systems, nebulization supplies, tracheostomy care items, suction equipment, and pediatric NIV masks. The company serves home medical equipment suppliers, respiratory specialists, hospitals, acute care facilities, and ambulatory surgery centers through direct sales teams and contracted supplier agreements (Premier, Vizient, ASC). Additional product lines include Breas ventilators, high-flow nasal cannula systems, and OEM repair parts. Sunset maintains manufacturing and distribution operations in Chicago and Elgin, Illinois, and has earned recognition as one of America's Fastest Growing Companies.